FreshAir Sensor
Lebanon, US · Founded 2013 · Delaware LLC
Founders & leadership
JB
Joseph BelBrunoExecutive Officer, Director
JJ
John J. O'TooleExecutive Officer, Director
NH
Norwood H. Davis, IIIExecutive Officer, Director
JC
Jesse C LaflammeDirector
IR
Ian RatcliffeDirector
Reported raises · per SEC filings
Form D private placements▶$3.7MraisedDec 2024 · 9 investors · Other TechnologyRule 506(b)
▶$3.7MraisedDec 2024 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John J. O'TooleExecutive Officer, Director
- Norwood H. Davis, IIIExecutive Officer, Director
- Jesse C LaflammeDirector
- Joseph BelBrunoExecutive Officer, Director
- Ian RatcliffeDirector
- Offering amount
- $10M
- Amount sold
- $3.7M
- First sale
- Nov 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1MraisedMay 2023 · 1 investors · Other TechnologyRule 506(b)
▶$1MraisedMay 2023 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jesse C LaflammeDirector
- Norwood H. Davis, IIIExecutive Officer, Director
- Ian RatcliffeDirector
- Joseph BelBrunoExecutive Officer, Director
- Molly HardieDirector
- John J. O'TooleExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $1M
- First sale
- May 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$14MraisedAug 2021 · 4 investors · Other TechnologyRule 506(b)
▶$14MraisedAug 2021 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ian RatcliffeDirector
- Jesse C LaflammeDirector
- John J. O'TooleExecutive Officer, Director
- Norwood H. Davis, IIIExecutive Officer, Director
- Joseph BelBrunoExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $14M
- First sale
- Aug 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedNov 2019 · 5 investors · Other TechnologyRule 506(b)
▶$4.5MraisedNov 2019 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John J. O'TooleExecutive Officer, Director
- Ian RatcliffeDirector
- Joseph BelBrunoExecutive Officer, Director
- Norwood H. Davis, IIIExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $4.5M
- First sale
- Oct 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedJan 2019 · 22 investors · Other TechnologyRule 506(b)
▶$3.5MraisedJan 2019 · 22 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ian RatcliffeDirector
- Joseph BelBrunoExecutive Officer, Director
- Norwood H. Davis, IIIExecutive Officer, Director
- John J. O'TooleExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Dec 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$4.2MraisedMay 2018 · 18 investors · Other TechnologyRule 506(b)
▶$4.2MraisedMay 2018 · 18 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph BelBrunoExecutive Officer, Director
- Norwood H. Davis, IIIExecutive Officer, Director
- John J. O'TooleExecutive Officer, Director
- Ian RatcliffeDirector
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- First sale
- May 2017
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$3.2MraisedFeb 2016 · 15 investors · Other TechnologyRule 506(b)
▶$3.2MraisedFeb 2016 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John J. O'TooleExecutive Officer, Director
- Ian RatcliffeDirector
- Norwood H. Davis, IIIExecutive Officer, Director
- Joseph BelBrunoExecutive Officer, Director
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- First sale
- Jan 2016
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $213.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.